Top 10 Companies in API Contract Manufacturing Market - Company Overview, Recent Developments and SWOT Analysis 2030
API Manufacturing an API, contract development and contract manufacturing organization is a company or organization that provides drug development and manufacturing services. Contract manufacturing is a process in which a manufacturer contracts with various companies to manufacture a product or component. Contract manufacturing of active pharmaceutical ingredients (APIs) is the complete manufacturing of pharmaceutical drugs with contract manufacturing support by other companies. Due to availability of trained workforce at low cost, favorable government policies and tax benefits, the worldwide API contract manufacturing market is expected to increase in demand during the forecast period. Several variables are expected to influence the overall development of the global API contract manufacturing market. The proliferation of low-cost labor in emerging markets is a primary driver of industry growth. Reduced investment costs due to availability of cheap labor in emerging Asian economies, easy access to new technologies in the industry and better utilization of resources in such locations are the major reasons for the growth of the API contract manufacturing market. Other factors such as increasing need to focus on core activities, growing demand to accelerate the drug development process, and significant reduction in time-to-market will all contribute to the growth of this market. The API contract manufacturing market is estimated to show the maximum growth rate during the forecast period.
Here are the top 10 companies operating in Propylene Market
Founded year: 1983
Headquarters: Mumbai, India
Number of employees: 37,000
Revenue: USD 331.39 Billion (2021)
Sun Pharmaceutical Industries Limited is the world's fourth largest specialty generic pharmaceutical company with a global revenue of over US$ 4.5 billion. Supported by more than 40 manufacturing facilities, they provide reliable, high-quality, affordable medicines to healthcare professionals and patients in more than 100 countries worldwide. It is the largest Indian company in emerging markets with a presence in more than 80 markets. Some of their key emerging markets are Brazil, Mexico, Russia, Romania and South Africa. Sun Pharmaceutical Industries Limited is a specialty pharmaceutical company that offers a wide range of pharmaceutical formulations such as branded generics and generic pharmaceuticals. The company's portfolio includes products for the treatment of psychiatric, neurological, nephrological, gastroenterological, orthopedic and ophthalmic diseases and disorders and cardiovascular diseases.
Founded Year: 1986
Revenue : USD 245.58 Billion (2021)
Headquarters: Hyderabad, Telangana, India
Employees: 24000
Aurobindo Pharma started operations in 1988–89 with a single unit manufacturing semi-synthetic penicillin in Pondicherry, Aurobindo Pharma became a public company in 1992 and listed its shares on the Indian Stock Exchange in 1995. Apart from being the market leader in semi-synthetic penicillins, it has a presence in key therapeutic segments such as neuroscience, cardiovascular, anti-retroviral, anti-diabetics, gastroenterology and anti-biotics. Aurobindo Pharma Ltd is a vertically integrated pharmaceutical company that manufactures and markets generic pharmaceuticals and active pharmaceutical ingredients.
Founded year: 1984
Revenue: USD 21.55 Billion (2021)
Employees: 10,000
Headquarters: Mumbai, Maharashtra
Aarti Drugs Ltd. was established in 1984 and is part of the $900 million Aarti Group of Industries with a strong R&D department at Tarapur, Maharashtra Industrial Development Corporation, close to the manufacturing locations. Aarti Drugs Ltd.'s manufacturing units are GMP certified, the company is in the process of achieving ISO 9002 compliance for all its units and one unit has already been accredited. The company is engaged in the manufacture of active pharmaceutical ingredients (APIs), pharma intermediates, specialty chemicals and formulations with its wholly owned subsidiary Pinnacle Life Science Pvt.
Founded Year: 1949
Revenue: USD 53.41 Billion (2021)
Headquarters: Mumbai, India
No of employees: 12000
Ipca Laboratories Limited was incorporated on 19 October 1949 under the name 'The Indian Pharmaceutical Combine Association Limited'. Ipca is a pharmaceutical company manufacturing and marketing over 350 formulations and 80 APIs covering different therapeutic segments. The company's products are now sold in more than 100 countries worldwide, the company has 17 manufacturing units in India manufacturing APIs and formulations for the global market.
Founded year: 1992
Revenue: USD 13.68 Billion (2021)
Headquartered: Mumbai
No of Employees: 890
Pharmaceuticals Limited Marksons Pharma has established world-class formulation manufacturing facilities by leveraging state-of-the-art technology, incorporating best practices and adhering to strict regulatory compliances. These are centers committed to manufacturing products of superior quality. Their state-of-the-art manufacturing facility in Goa is spread over 18,000 square meters. It is home to state-of-the-art product innovation and formulation development processes that meet global needs. The company, engaged in the manufacture of prescription drugs, caters to areas such as oncology, gastroenterology, antidiabetic, cardiovascular, pain management, gynecology and others.
API Contract Manufacturing Market is estimated to be US$ 182.00 billion by 2030 with a CAGR of 7.4% during the forecast period
Founded year: 1961
Headquarters: Gurgaon, Haryana, India
No of Employees: 10,983
Ranbaxy Laboratories Limited was an Indian multinational pharmaceutical company incorporated in India in 1961 and remained an entity till 2014. The company went public in 1973, Ranbaxy has changed ownership twice in its history. Ranbaxy was started by Ranveer Singh and Gurbax Singh in 1937 as a distributor for the Japanese company Shionogi. Ranbaxy's name combines the names of its founders: Ranbir and Gurbax. eva Pharmaceutical Industries Limited (Teva) discovers, develops, manufactures and markets generic and specialty medicines. The company provides specialty medicines to treat disorders of the central nervous system (CNS), respiratory, dermatology, cancer, women's health and other diseases.
Founded year: 1901
Headquarters: Tel Aviv, Israel
Revenue: USD 15.58 Billion (2021)
No of Employees: 37,537
Teva Pharmaceutical Industries Ltd is an Israeli-based pharmaceutical company, the company operates in three segments: North America, Europe and international markets, each business segment manages a complete product portfolio including generic, specialty and over-the-counter products in its territory. Apart from these three segments, the company has other activities, primarily sales of active pharmaceutical ingredients to third parties, certain contract manufacturing services and a licensing platform offering a portfolio of products to other pharmaceutical companies through its subsidiary Medis. Teva Pharmaceuticals Industries Limited discovers, develops, manufactures and markets generic and specialty drugs. The company provides specialty drugs to treat disorders of the central nervous system, respiratory, dermatology, cancer, women's health and other diseases.
Funded Year: 1924
Headquarters: Mumbai, Maharashtra, India
Revenue: USD 31,988.62 Million (2021)
No of Employees: 3500
Glaxo SmithKline Pharmaceutical Ltd is an Indian research-based pharmaceutical and healthcare company and a subsidiary of GSK. The company's product portfolio includes prescription drugs and vaccines, its prescription drugs are in therapeutic areas such as immunology, dermatology, gynecology, diabetes, oncology, cardiovascular disease and respiratory disease. It also offers a range of vaccines for the prevention of invasive diseases caused by hepatitis A, hepatitis B, H, influenza, chicken pox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer and others.
.
Founded Year: 1984
Headquarters: Mumbai, Maharashtra, India
Revenue: USD 127.71 Billion (2021)
Piramal Pharma Solutions is an Indian multinational company with presence in various sectors such as healthcare, life sciences, drug discovery, financial services, alternative investments and real estate. The Piramal Group has interests in a portfolio of businesses including services (Piramal Enterprises Limited), pharmaceuticals (Piramal Pharma Limited) and real estate, with operations in 30 countries and brand presence in over 100 markets, with a group turnover of ~$1.9 billion in the financial year 2022. Piramal Pharma Limited offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities in 15 global facilities and a global distribution network in over 100 countries. PPL includes Piramal Pharma Solutions, an integrated contract development and manufacturing arm.
Founded Year: 2018
Revenue: 15,757.30 Million (2021)
Headquarters: Chennai, Tamil Nadu
No of Employees: 2,254
Active pharma sciences ltd., is a young, dynamic, and entrepreneurial and customer oriented API manufacturer. Solara Active Pharma Sciences Limited manufactures pharmaceutical products, the company focuses on manufacturing, processing, formulation, trading, distribution and trading of active pharmaceutical ingredients. Solara Active Sciences serves patients in India, the company offers anesthetic, analgesic, antiviral, retinoid, antigout, cardiovascular, anti-infective, antitussive and other products and services.
Recent Developments:
- In May 2022, Piramal Pharma Limited's Pharma Solutions business, a leading contract development and manufacturing organization, in May 2022, a new active pharmaceutical ingredient plant at the company's site in Aurora, Ontario, came online and successfully completed its initial production run.
- In November 2022, Solara Active Pharma Sciences Limited, a leading provider of pure play active pharmaceutical ingredients, is pleased to announce that its new state-of-the-art multi-purpose API manufacturing facility in Visakhapatnam, Andhra Pradesh has been granted 'Certificate of Competence'. Production of Ibuprofen API, first international regulatory approval for this new facility, from the European Directorate for the Quality of Medicines.
- In December 2022, Sk pharmaco is a global CDMO, SK Inc. As part of the, they announced in December 2022, that they have launched SK Biotek Ireland Analytical Services to provide full CGMP testing services including testing of active pharmaceutical ingredients based at SK Biotek Ireland based at SK Biotek's plant.